![Sun Pharma: FDA accepts NDA for dermatological drug Deuruxolitinib Sun Pharma Q2 FY24 Results: Consolidated PAT Rises to Rs. 2375.51 Cr](https://www.sharemarketexpress.com/wp-content/uploads/2023/10/500x300_197182-sun-pharma-4-1-1-600x400.jpg)
Sun Pharma: FDA accepts NDA for dermatological drug Deuruxolitinib
Sun Pharmaceutical Industries Ltd, a leading drug manufacturer, announced a significant milestone on Friday as the United States Food and…
Sun Pharmaceutical Industries Ltd, a leading drug manufacturer, announced a significant milestone on Friday as the United States Food and…